News Tanda Biotech: Revolutionizing Bioproduction for a Sustainable Future Tanda Biotech is a participant in cohort 2 of Resurgence, a cleantech accelerator led by the University of Chicago’s Polsky Center for Entrepreneurship and Innovation in partnership with the Pritzker...
News UChicago’s Chuan He Recognized for Real-World Impact of Research University of Chicago researcher Chuan He has been recognized for the potential real-world impact of his work – including a method to dramatically increase crop yields and an innovative liquid...
Technology Novel Nano-Formulation For Multi-TLR Agonists To Boost Immune Responses Against Solid Tumors Toll-like receptor (TLR) agonists are considered promising alternatives for the estimated 50 – 75% of all cancer patients who are non-responsive to checkpoint inhibitors, and immune activation is enhanced upon…
Technology Small Molecule Therapeutics For Inducing Trained Innate Immunity And Enhanced Anti-Tumor Responses Small molecule drugs developed to induce trained immunity in macrophage cells resulting in a heightened pro-inflammatory response without triggering a primary immune response The Unmet Need: Trained immunity induction that…
Technology Novel Compounds for the Potentiation of Antibiotic Resistance in Staphylococcus Aureus Currently there is no available vaccine for the prophylaxis of S. Aureus mediated infections such as MRSA, and antibiotics such as beta lactams and oxacillin are most commonly used for…
Technology Novel Mycobacterial Small Molecules That Bind MR1 And Are Activating Or Antagonistic For MR1-Restricted T cells. TB bacterium, Mycobacterium tuberculosis (M. tuberculosis), is extremely slow growing compared to other bacteria and is naturally resistant to many of the powerful antibiotics that are effective against other bacterial…
Technology OSCA: A System For Efficient Construction Of Adenovirus Vectors Adenoviruses (Ad) are a non-enveloped linear double-stranded DNA viruses with over 50 serotypes identified in humans. They have received significant attention as an in vitro and in vivo gene delivery…
Technology Neutralizing Monoclonal Antibodies Against SARS-CoV-2 The landscape of SARS-CoV-2 is experiencing a novel development of viral variants harboring mutations that can escape even the most highly potent antibodies against the receptor binding domain. These variants…
Page Science and Technology Commercialization Science and Technology Commercialization The Polsky Center connects Chicago Booth students with University of Chicago faculty and researchers at the National Laboratories who are specifically looking for Booth students to...
Page Science and Technology Commercialization Science and Technology Commercialization The Polsky Center connects graduate students with University of Chicago faculty and researchers at the National Laboratories who are specifically looking for talented students to serve...
